Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kramer, Gero"" wg kryterium: Autor


Tytuł:
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Autorzy:
Rebhan, KatharinaAff1, Aff2
Stelzer, Philipp D.
Pradere, BenjaminAff1, Aff4
Rajwa, PawelAff1, Aff5
Kramer, Gero
Hofmann, Bernd
Resch, Irene
Yurdakul, Ozan
Laccone, Franco A.
Bujalkova, Maria Gerykova
Smogavec, Mateja
Tan, Yen Y.
Ristl, Robin
Shariat, Shahrokh F.Aff1, Aff9, Aff10, Aff11, Aff12, Aff13, Aff14
Egger, GerdaAff15, Aff16, Aff17
Hassler, Melanie R.Aff1, IDs00345023045354_cor16
Pokaż więcej
Źródło:
World Journal of Urology. 41(8):2091-2097
Czasopismo naukowe
Tytuł:
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Autorzy:
Gillessen, Silke
Bossi, Alberto
Davis, Ian D.
de Bono, Johann
Fizazi, Karim
James, Nicholas D.
Mottet, Nicolas
Shore, Neal
Small, Eric
Smith, Matthew
Sweeney, Christopher J.
Tombal, Bertrand
Antonarakis, Emmanuel S.
Aparicio, Ana M.
Armstrong, Andrew J.
Attard, Gerhardt
Beer, Tomasz M.
Beltran, Himisha
Bjartell, Anders
Blanchard, Pierre
Briganti, Alberto
Bristow, Rob G.
Bulbul, Muhammad
Caffo, Orazio
Castellano, Daniel
Castro, Elena
Cheng, Heather H.
Chi, Kim N.
Chowdhury, Simon
Clarke, Caroline S.
Clarke, Noel
Daugaard, Gedske
De Santis, Maria
Duran, Ignacio
Eeles, Ross
Efstathiou, Eleni
Efstathiou, Jason
Ekeke, Onyeanunam Ngozi
Evans, Christopher P.
Fanti, Stefano
Feng, Felix Y.
Fonteyne, Valerie
Fossati, Nicola
Frydenberg, Mark
George, Dan
Gleave, Martin
Gravis, Gwenaelle
Halabi, Susan
Heinrich, Daniel
Herrmann, Ken
Higano, Celestia
Hofman, Michael S.
Horvath, Lisa G.
Hussain, Maha
Jereczek-Fossa, Barbara A.
Jones, Rob
Kanesvaran, Ravindran
Kellokumpu-Lehtinen, Pirkko-Liisa
Khauli, Raja B.
Klotz, Laurence
Kramer, Gero
Leibowitz, Raja
Logothetis, Christopher
Mahal, Brandon
Maluf, Fernando
Mateo, Joaquin
Matheson, David
Mehra, Niven
Merseburger, Axel
Morgans, Alicia K.
Morris, Michael J.
Mrabti, Hind
Mukherji, Deborah
Murphy, Declan G.
Murthy, Vedang
Nguyen, Paul L.
Oh, William K.
Ost, Piet
O’Sullivan, Joe M.
Padhani, Anwar R.
Pezaro, Carmel J.
Poon, Darren M.C.
Pritchard, Colin C.
Rabah, Danny M.
Rathkopf, Dana
Reiter, Robert E.
Rubin, Mark A.
Ryan, Charles J.
Saad, Fred
Sade, Juan Pablo
Sartor, Oliver
Scher, Howard I.
Sharifi, Nima
Skoneczna, Iwona
Soule, Howard
Spratt, Daniel E.
Srinivas, Sandy
Sternberg, Cora N.
Steuber, Thomas
Suzuki, Hiroyoshi
Sydes, Matthew R.
Taplin, Mary-Ellen
Tilki, Derya
Türkeri, Levent
Turco, Fabio
Uemura, Hiroji
Uemura, Hirotsugu
Ürün, Yüksel
Vale, Claire L.
van Oort, Inge
Vapiwala, Neha
Walz, Jochen
Yamoah, Kosj
Ye, Dingwei
Yu, Evan Y.
Zapatero, Almudena
Zilli, Thomas
Omlin, Aurelius
Pokaż więcej
Źródło:
In European Journal of Cancer May 2023 185:178-215
Czasopismo naukowe
Tytuł:
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Autorzy:
Gillessen, Silke
Bossi, Alberto
Davis, Ian D.
de Bono, Johann
Fizazi, Karim
James, Nicholas D.
Mottet, Nicolas
Shore, Neal
Small, Eric
Smith, Matthew
Sweeney, Christopher
Tombal, Bertrand
Antonarakis, Emmanuel S.
Aparicio, Ana M.
Armstrong, Andrew J.
Attard, Gerhardt
Beer, Tomasz M.
Beltran, Himisha
Bjartell, Anders
Blanchard, Pierre
Briganti, Alberto
Bristow, Rob G.
Bulbul, Muhammad
Caffo, Orazio
Castellano, Daniel
Castro, Elena
Cheng, Heather H.
Chi, Kim N.
Chowdhury, Simon
Clarke, Caroline S.
Clarke, Noel
Daugaard, Gedske
De Santis, Maria
Duran, Ignacio
Eeles, Ros
Efstathiou, Eleni
Efstathiou, Jason
Ngozi Ekeke, Onyeanunam
Evans, Christopher P.
Fanti, Stefano
Feng, Felix Y.
Fonteyne, Valerie
Fossati, Nicola
Frydenberg, Mark
George, Daniel
Gleave, Martin
Gravis, Gwenaelle
Halabi, Susan
Heinrich, Daniel
Herrmann, Ken
Higano, Celestia
Hofman, Michael S.
Horvath, Lisa G.
Hussain, Maha
Jereczek-Fossa, Barbara Alicja
Jones, Robert
Kanesvaran, Ravindran
Kellokumpu-Lehtinen, Pirkko-Liisa
Khauli, Raja B.
Klotz, Laurence
Kramer, Gero
Leibowitz, Raya
Logothetis, Christopher J.
Mahal, Brandon A.
Maluf, Fernando
Mateo, Joaquin
Matheson, David
Mehra, Niven
Merseburger, Axel
Morgans, Alicia K.
Morris, Michael J.
Mrabti, Hind
Mukherji, Deborah
Murphy, Declan G.
Murthy, Vedang
Nguyen, Paul L.
Oh, William K.
Ost, Piet
O'Sullivan, Joe M.
Padhani, Anwar R.
Pezaro, Carmel
Poon, Darren M.C.
Pritchard, Colin C.
Rabah, Danny M.
Rathkopf, Dana
Reiter, Robert E.
Rubin, Mark. A.
Ryan, Charles J.
Saad, Fred
Pablo Sade, Juan
Sartor, Oliver A.
Scher, Howard I.
Sharifi, Nima
Skoneczna, Iwona
Soule, Howard
Spratt, Daniel E.
Srinivas, Sandy
Sternberg, Cora N.
Steuber, Thomas
Suzuki, Hiroyoshi
Sydes, Matthew R.
Taplin, Mary-Ellen
Tilki, Derya
Türkeri, Levent
Turco, Fabio
Uemura, Hiroji
Uemura, Hirotsugu
Ürün, Yüksel
Vale, Claire L.
van Oort, Inge
Vapiwala, Neha
Walz, Jochen
Yamoah, Kosj
Ye, Dingwei
Yu, Evan Y.
Zapatero, Almudena
Zilli, Thomas
Omlin, Aurelius
Pokaż więcej
Źródło:
In European Urology March 2023 83(3):267-293
Czasopismo naukowe
Tytuł:
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
Autorzy:
Bjartell, Anders
Costa, Luis
Kramer, Gero
Zurawski, Bogdan
Galli, Luca
Werbrouck, Patrick
Ecke, Thorsten
Parikh, Omi
Bennamoun, Mostefa
Garcia Freire, Camilo
Peer, Avivit
Ljungberg, Börje
Cicin, Irfan
Smith, Emma
Lukac, Martin
Wapenaar, Robert
Chowdhury, Simon
Pokaż więcej
Źródło:
In European Urology Open Science November 2022 45:12-22
Czasopismo naukowe
Tytuł:
Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies
Autorzy:
Dillinger, ThomasAff1, Aff2
Sheibani-Tezerji, RahelehAff1, Aff2
Pulverer, Walter
Stelzer, InesAff1, Aff4
Hassler, Melanie R.Aff2, Aff5
Scheibelreiter, Janine
Pérez Malla, Carlos Uziel
Kuroll, Madeleine
Domazet, Sandra
Redl, Elisa
Ely, SarahAff1, Aff6
Brezina, Stefanie
Tiefenbacher, AndreasAff1, Aff2
Rebhan, Katharina
Hübner, Nicolai
Grubmüller, Bernhard
Mitterhauser, MarkusAff1, Aff8
Hacker, Marcus
Weinhaeusel, Andreas
Simon, JuditAff1, Aff4
Zeitlinger, MarkusAff1, Aff6
Gsur, Andrea
Kramer, Gero
Shariat, Shahrokh F.Aff5, Aff9, Aff10, Aff11, Aff12, Aff13, Aff14, Aff15
Kenner, LukasAff2, Aff9, Aff16, Aff17
Egger, GerdaAff1, Aff2, Aff9, IDs12943021014450_cor26
Pokaż więcej
Źródło:
Molecular Cancer. 21(1)
Czasopismo naukowe
Tytuł:
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study
Autorzy:
Fizazi, Karim
Kramer, Gero
Eymard, Jean-Christophe
Sternberg, Cora N
de Bono, Johann
Castellano, Daniel
Tombal, Bertrand
Wülfing, Christian
Liontos, Michael
Carles, Joan
Iacovelli, Roberto
Melichar, Bohuslav
Sverrisdóttir, Ásgerður
Theodore, Christine
Feyerabend, Susan
Helissey, Carole
Oudard, Stéphane
Facchini, Gaetano
Poole, Elizabeth M
Ozatilgan, Ayse
Geffriaud-Ricouard, Christine
Bensfia, Samira
de Wit, Ronald
Pokaż więcej
Źródło:
In The Lancet Oncology November 2020 21(11):1513-1525
Czasopismo naukowe
Tytuł:
Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
Autorzy:
Huebner, Nicolai AlexanderAff1, Aff2
Korn, Stephan
Resch, Irene
Grubmüller, Bernhard
Gross, Tobias
Gale, Robert
Kramer, Gero
Poetsch, Nina
Clauser, Paola
Haitel, Andrea
Fajkovic, HarunAff1, Aff2, Aff5
Shariat, Shahrokh F.Aff1, Aff6, Aff7, Aff8, Aff9
Baltzer, Pascal A.Aff2, Aff3
Pokaż więcej
Źródło:
European Radiology. 31(6):3754-3764
Czasopismo naukowe
Tytuł:
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry
Autorzy:
Bjartell, AndersAff1, Aff2
Lumen, Nicolaas
Maroto, Pablo
Paiss, Thomas
Gomez-Veiga, Francisco
Birtle, Alison
Kramer, Gero
Kalinka, Ewa
Spaëth, Dominique
Feyerabend, Susan
Matveev, Vsevolod
Lefresne, Florence
Lukac, Martin
Wapenaar, Robert
Costa, Luis
Chowdhury, Simon
Pokaż więcej
Źródło:
Targeted Oncology. 16(3):357-367
Czasopismo naukowe
Tytuł:
Prediction of response and survival after standardized treatment with 7400 MBq Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer
Autorzy:
Rasul, Sazan
Hartenbach, Markus
Wollenweber, Tim
Kretschmer-Chott, Elisabeth
Grubmüller, Bernhard
Kramer, Gero
Shariat, ShahrokhAff2, Aff3, Aff4, Aff5, Aff6
Wadsak, WolfgangAff1, Aff7
Mitterhauser, MarkusAff1, Aff8
Pichler, Verena
Vraka, Chrysoula
Hacker, Marcus
Haug, Alexander R.Aff1, Aff9
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 48(5):1650-1657
Czasopismo naukowe
Tytuł:
Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
Autorzy:
Chowdhury, Simon
Bjartell, Anders
Lumen, Nicolaas
Maroto, Pablo
Paiss, Thomas
Gomez-Veiga, Francisco
Birtle, Alison
Kramer, Gero
Kalinka, Ewa
Spaëth, Dominique
Feyerabend, Susan
Matveev, Vsevolod
Lefresne, Florence
Lukac, Martin
Wapenaar, Robert
Costa, Luis
Pokaż więcej
Źródło:
Targeted Oncology. 15(3):301-315
Czasopismo naukowe
Tytuł:
Clinical outcome of standardized Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
Autorzy:
Rasul, Sazan
Hacker, Marcus
Kretschmer-Chott, Elisabeth
Leisser, Asha
Grubmüller, Bernhard
Kramer, Gero
Shariat, ShahrokhAff2, Aff3, Aff4, Aff5, Aff6
Wadsak, WolfgangAff1, Aff7
Mitterhauser, MarkusAff1, Aff8
Hartenbach, Markus
Haug, Alexander R.Aff1, Aff9
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 47(3):713-720
Czasopismo naukowe
Tytuł:
Prospective evaluation of the performance of [Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy
Autorzy:
Abufaraj, MohammadAff1, Aff2
Grubmüller, BernhardAff1, Aff3
Zeitlinger, MarkusAff4, Aff5
Kramer, Gero
Seitz, ChristianAff1, Aff3
Haitel, Andrea
Baltzer, PascalAff3, Aff7
Hacker, Marcus
Wadsak, WolfgangAff8, Aff9
Pfaff, Sarah
Wiatr, Tomasz
Mitterhauser, MarkusAff5, Aff8
Shariat, Shahrokh F.Aff1, Aff11, Aff12, Aff13, Aff14
Hartenbach, MarkusAff3, Aff8
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 46(10):2169-2177
Czasopismo naukowe
Tytuł:
Response assessment using Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Autorzy:
Grubmüller, BernhardAff1, Aff2
Senn, Daniela
Kramer, Gero
Baltzer, PascalAff2, Aff4
D’Andrea, David
Grubmüller, Karl Hermann
Mitterhauser, MarkusAff3, Aff6
Eidherr, Harald
Haug, Alexander R.
Wadsak, WolfgangAff3, Aff7
Pfaff, Sarah
Shariat, Shahrokh F.Aff1, Aff8, Aff9
Hacker, Marcus
Hartenbach, MarkusAff2, Aff3
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 46(5):1063-1072
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies